-
Ukraine denies Moscow claim of seizing strategic stronghold
-
Jefferson-Wooden holds off Richardson for Eugene 100m win
-
Dinusha shines for Sri Lanka on second day of West Indies Test
-
Stopping Haaland no mystery for Brazil, says Ancelotti
-
Julian Quinones, Mexico's not-so-secret World Cup weapon
-
Coach says Morocco 'no longer a surprise' after reaching World Cup quarters
-
Erasmus celebrates equalling record with win for weakened Springboks
-
Tuipulotu guides Scotland past Argentina with record score
-
'I'm going with him': families fear for bodies of Venezuela's quake dead
-
'Proud' Marsch says Canada better side in World Cup exit
-
Venezuela quake death toll rises to nearly 3,000
-
Norway must handle occasion against Brazil, says Solbakken
-
England unhappy with Rita Ora show before T20 World Cup final
-
Bethell upstages 'unbelievable' Sooryavanshi as England beat India
-
Morocco end Canada World Cup dream to reach quarters as France face Philly heat
-
'No point in racing' says frustrated Verstappen after British GP qualifying
-
Ruthless Morocco break Canadian hearts to reach World Cup quarters
-
Tour de France yellow gives Vingegaard crash closure
-
An 'angel' in darkness after Venezuela's deadly quakes
-
Smiling Antonelli proves all-round quality with pole at British GP
-
US turns 250 with Trump center stage
-
Vingegaard takes Tour de France lead with 'perfect start'
-
South Africa beat 13-man England in Nations Championship
-
Osaka eyes Sabalenka revenge in Wimbledon last 16
-
Vingegaard takes Tour de France lead as Visma win opening stage
-
Bethell upstages Sooryavanshi as England beat India in 2nd T20
-
Swiatek doesn't care about results after Wimbledon exit
-
Antonelli outpaces Ferraris to claim pole for British Grand Prix
-
England bid to emulate Lionesses and Red Roses in T20 World Cup final
-
Tens of thousands rally in France against sexual violence
-
French Open champ Zverev into Wimbledon last 16
-
Antonelli takes pole position for British Grand Prix
-
Teenage star Sooryavanshi out for 14 on India debut
-
'World Cup starts now' as Spain, Portugal clash in last 16
-
Splish-splash! Parisians and tourists soak in the Seine
-
A 'garden inside the Garden': More details of Swift-Kelce wedding emerge
-
Swiatek dumped out of Wimbledon by Eala, Serena withdraws from doubles
-
Serena Williams pulls out of Wimbledon doubles with knee injury
-
Swiatek's Wimbledon title defence ended by Philippines' Eala
-
Former champ Rybakina crashes out at Wimbledon
-
US celebrates 250th birthday as Trump warns of enemy within
-
Mass protests in Germany fail to stop far-right AfD congress
-
Farrell hails Ireland character in Wallabies win but says work to do
-
Ireland pip Australia 33-31 in Nations Championship nailbiter
-
Ireland edge Australia 33-31 in Nations Championship nailbiter
-
Antonelli edges Hamilton in sprint to extend title lead
-
Mali hit by new wave of coordinated rebel attacks
-
Rennie 'relief' as All Blacks tenure begins with narrow win over France
-
Hosts Canada, Mexico and USA thrive in their World Cup
-
Europe's baked rice bowl seeks escape from drought
Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
Ch.Campbell--AT